Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7842672 Phosphonate inhibitors of HCV

Patent 7842672 was granted and assigned to Gilead Sciences on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 11 Sep, 2024

"update inverses"

Golden AI

edited on 11 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

Edits on 19 Jun, 2024

"update inverses"

Golden AI

edited on 19 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12012431 Methods of preparing 1′-cyano nucleosides

Edits on 13 Jun, 2024

"update inverses"

Golden AI

edited on 13 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

Edits on 8 May, 2024

"update inverses"

Golden AI

edited on 8 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11975016 2′-substituted-N

"update inverses"

Golden AI

edited on 8 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

"update inverses"

Golden AI

edited on 8 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11975012 Remdesivir treatment methods

Edits on 29 Mar, 2024

"update inverses"

Golden AI

edited on 29 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

Edits on 14 Mar, 2024

"update inverses"

Golden AI

edited on 14 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11926645 Compounds and methods for treatment of viral infections

Edits on 22 Feb, 2024

"update inverses"

Golden AI

edited on 22 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11903953 Remdesivir treatment methods

Edits on 27 Dec, 2023

"update inverses"

Golden AI

edited on 27 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections

Edits on 31 Oct, 2023

"Add patent abstract"

Golden AI

edited on 31 Oct, 2023

Edits made to:

Article (+79 characters)

Article

Patent abstract

A compound of Formula I, Formula II, Formula III, or Formula IV:

Edits on 11 Oct, 2023

"update inverses"

Golden AI

edited on 11 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11780844 Compounds and methods for treatment of viral infections

Edits on 18 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 18 Sep, 2023

Edits made to:

Infobox (+11 properties)

Infobox

Patent Inventor Names

Alan X. Huang0

Choung U. Kim0

Constantine G. Boojamra0

David A. Oare0

James M. Chen0

Jason K. Perry0

Kuei-Ying Lin0

Lijun Zhang0

Oliver L. Saunders0

Richard L. Mackman0

Sundaramoorthi Swaminathan0

Edits on 26 Jul, 2023

"update inverses"

Golden AI

edited on 26 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11707480 Highly active compounds against COVID-19

Edits on 19 Jul, 2023

"update inverses"

Golden AI

edited on 19 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

Edits on 15 Jul, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 15 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07842672 Phosphonate inhibitors of HCV US Patent 7842672 Phosphonate inhibitors of HCV

Infobox

Patent Number

078426720

Patent Number

78426720

Edits on 20 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 20 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=078426720

Edits on 4 Apr, 2023

"Entity importer update"

Golden AI

edited on 4 Apr, 2023

Infobox

Is a

Patent

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

078426720

Date of Patent

November 30, 2010

Patent Application Number

118253950

Date Filed

July 6, 2007

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=078426720

Patent Primary Examiner

‌

Patrick T. Lewis

Edits on 3 Jun, 2022

"Entity importer update"

Golden AI

edited on 3 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=07842672

Edits on 6 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 6 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 07842672 Phosphonate inhibitors of HCV

Infobox

Is a

Patent

Current assignee

Gilead Sciences

Patent jurisdiction

United States Patent and Trademark Office

Patent number

07842672

Date of patent

November 30, 2010

Patent application number

11825395

Date Filed

July 6, 2007

Patent primary examiner

‌

Patrick T. Lewis

Find more entities like US Patent 7842672 Phosphonate inhibitors of HCV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.